Novo Holdings Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Novo Holdings

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $5.27 Million - $7.4 Million	-53,300 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $4.93 Million - $7.88 Million	-75,000 Reduced 58.46%	53,300 $5.17 Million
Q1 2021 May 17, 2021	BUY	$64.07 - $91.75 $2.9 Million - $4.15 Million	45,200 Added 54.39%	128,300 $8.77 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $97,604 - $147,360	-1,500 Reduced 1.77%	83,100 $7.12 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $884,805 - $2.26 Million	30,500 Added 56.38%	84,600 $6.19 Million

Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $500,682 - $1.04 Million	18,200 Added 50.7%	54,100 $1.84 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $1.34 Million - $1.78 Million	35,900 New	35,900 $1.5 Million

565K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.49B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.